CYP19A1 and breast carcinoma: Different results, i.e., lack of interaction between formestane, a second-generation steroid aromatase inhibitor (currently no longer used in the treatment of breast cancer), and phytoestrogens derived from the root bug extract, were shown in the animal model by Nißlein et al. [35].